Hematology and Oncology Association at Bridgepoint Hem Onc Bridgepoint

Tupelo, Mississippi 38801

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor — Completed